President's Message

Barbara Gordon, ASBMB executive director, to retire in 2021

Toni M. Antalis
By Toni M. Antalis
November 17, 2020

It is with mixed feelings that I am writing to let you know that the American Society for Biochemistry and Molecular Biology’s longtime executive director, Barbara A. Gordon, announced today that she will be retiring in early 2021.

Barbara A. Gordon has been executive director of the ASBMB since 2003.

Barbara has spent just about her entire career at the society, and we couldn’t have asked for a more committed and caring leader. She began working for the Journal of Biological Chemistry in 1972 and went on to manage the society’s meetings and its journals before being appointed executive director in 2003. During her tenure, she oversaw the journals’ transition to online publishing and, most recently, their transition to open access. She also oversaw the formation of new committees and programs, such as the undergraduate degree-accreditation program and certification exam, the IMAGE grant-writing workshop, and the new MOSAIC program for diverse young investigators. Her list of accomplishments is long and impressive.

Barbara has been tremendously supportive and encouraging to all members of our ASBMB community, and we will most certainly miss her. She has freely shared her wisdom, intelligence and humor with all who have had the pleasure of working with her. On behalf of the Council and all who have benefited from working with Barbara, I thank her for her exceptional service to the society and congratulate her on her well-deserved retirement.

The Council will soon begin the search process for a new executive director and will keep you updated on its progress. We will work closely with Barbara, the headquarters staff and the committees to ensure that there is a smooth transition.

Toni M. Antalis
Toni M. Antalis

Toni Antalis is a professor of physiology at the University of Maryland School of Medicine, where she is also the associate director for training and education for the Greenebaum Cancer Center and the director of the graduate program in molecular medicine. She began her term as the ASBMB’s president on July 1.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

James Siedow (1947–2020)
Retrospective

James Siedow (1947–2020)

November 30, 2020

The former Duke University administrator and plant researcher is remembered for his leadership, discoveries and kindness.

Targeting two-faced nuclear receptors to fight cancer
News

Targeting two-faced nuclear receptors to fight cancer

November 24, 2020

For small-molecule cancer drugs, context is everything. Drugs that ameliorate cancer in some tissues may increase the cancer risk in others. Researcher Stephen Safe has turned this challenge into an opportunity.

Gerald S. Berenson (1922–2018)
Retrospective

Gerald S. Berenson (1922–2018)

November 23, 2020

A physician–scientist who devoted more than six decades to understanding the causes of cardiovascular disease, Berenson was one of the earliest members of the American Society for Biochemistry and Molecular Biology.

Collins, Kim and Qian receive Pioneer grants; McKnight wins Welch award; remembering Donald Comb
Member News

Collins, Kim and Qian receive Pioneer grants; McKnight wins Welch award; remembering Donald Comb

November 23, 2020

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

November 23, 2020

The American Society for Biochemistry and Molecular Biology welcomed more than 140 new members in July.

“You’ve got … to get outside of your comfort zone”
Interview

“You’ve got … to get outside of your comfort zone”

November 20, 2020

Wayne Fairbrother leads a department at Genentech tasked with validating disease-associated targets and determining whether they could be feasible for drug development.